E2F1 and ovarian cancer: The subcutaneous tumorigenesis assay revealed that E2F1 knockdown reduced the volume and weight of tumors formed from ovarian cancer cells (Supplementary Fig. 9g-i), which phenocopied the effect of NSUN2 deficiency.